We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 664 results
  1. A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants

    The most common histological subtypes of cutaneous melanoma include superficial spreading and nodular melanoma. However, the spectrum of somatic...

    Ivana Ticha, Jan Hojny, ... Pavel Dundr in Scientific Reports
    Article Open access 19 November 2019
  2. Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research

    Splicing factor 3B subunit 1 (SF3B1) is the largest component of SF3b protein complex which is involved in the pre-mRNA splicing mechanism. Somatic...

    Asmaa Samy, Mehmet Kemal Ozdemir, Reda Alhajj in Scientific Reports
    Article Open access 15 February 2023
  3. Clinical and molecular study of radiation-induced gliomas

    In this study, we provide a comprehensive clinical and molecular biological characterization of radiation-induced gliomas (RIG), including a risk...

    Katerina Trkova, David Sumerauer, ... Michal Zapotocky in Scientific Reports
    Article Open access 07 February 2024
  4. Genomic analysis as a tool to infer disparate phylogenetic origins of dysembryoplastic neuroepithelial tumors and their satellite lesions

    Dysembryoplastic neuroepithelial tumor (DNET) is a low-grade brain tumor commonly associated with drug-resistant epilepsy. About half of DNETs are...

    Yea**a Lee, Jeyul Yang, ... Ji Hoon Phi in Scientific Reports
    Article Open access 13 January 2023
  5. Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment

    Biliary tract cancers are rare cancers with poor prognosis due to a lack of therapeutic options, especially after the failure of first-line systemic...

    Bernhard Doleschal, Hossein Taghizadeh, ... Holger Rumpold in Scientific Reports
    Article Open access 18 September 2023
  6. Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas

    Glioblastomas (GBMs) are the most common and lethal primary brain malignancy in adults. Oncolytic virus (OV) immunotherapies selectively kill GBM...

    Dileep D. Monie, Cristina Correia, ... Hu Li in Scientific Reports
    Article Open access 27 May 2021
  7. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells

    Patient-derived xenografts (PDX) are widely used as human cancer models. Previous studies demonstrated clonal discordance between PDX and primary...

    Naomi Kawashima, Yuichi Ishikawa, ... Hitoshi Kiyoi in Nature Communications
    Article Open access 25 March 2022
  8. The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans

    Multiple myeloma (MM) is a heterogeneous disease characterized by frequent MYC translocations. Sporadic MYC activation in the germinal center of...

    Francesco Maura, David G. Coffey, ... Marta Chesi in Nature Communications
    Article Open access 07 May 2024
  9. Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

    To inform clinical trial design and real-world precision pediatric oncology practice, we classified diagnoses, assessed the landscape of mutations,...

    Suzanne J. Forrest, Hersh Gupta, ... Katherine A. Janeway in Nature Communications
    Article Open access 11 July 2024
  10. Shared and distinct genetic etiologies for different types of clonal hematopoiesis

    Clonal hematopoiesis (CH)—age-related expansion of mutated hematopoietic clones—can differ in frequency and cellular fitness by CH type (e.g.,...

    Derek W. Brown, Liam D. Cato, ... Mitchell J. Machiela in Nature Communications
    Article Open access 08 September 2023
  11. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

    Inflammation has long been recognized to contribute to cancer development, particularly across the gastrointestinal tract. Patients with inflammatory...

    Walid K. Chatila, Henry Walch, ... Rona Yaeger in Nature Communications
    Article Open access 07 January 2023
  12. Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network

    Identification of genotypes is crucial for treatment of glioma. Here, we developed a method to predict tumor genotypes using a pretrained...

    Ryohei Fukuma, Takufumi Yanagisawa, ... Haruhiko Kishima in Scientific Reports
    Article Open access 30 December 2019
  13. Degradation of D-2-hydroxyglutarate in the presence of isocitrate dehydrogenase mutations

    D-2-Hydroxyglutarate (D-2-HG) is regarded as an oncometabolite. It is found at elevated levels in certain malignancies such as acute myeloid...

    Raffaela S. Berger, Lisa Ellmann, ... Katja Dettmer in Scientific Reports
    Article Open access 15 May 2019
  14. Using arterial–venous analysis to characterize cancer metabolic consumption in patients

    Understanding tumor metabolism holds the promise of new insights into cancer biology, diagnosis and treatment. To assess human cancer metabolism,...

    Nanxiang ** Ge in Nature Communications
    Article Open access 23 June 2020
  15. Directional integration and pathway enrichment analysis for multi-omics data

    Omics techniques generate comprehensive profiles of biomolecules in cells and tissues. However, a holistic understanding of underlying systems...

    Mykhaylo Slobodyanyuk, Alexander T. Bahcheli, ... Jüri Reimand in Nature Communications
    Article Open access 07 July 2024
  16. Diverse alterations associated with resistance to KRAS(G12C) inhibition

    Inactive state-selective KRAS(G12C) inhibitors 1 8 demonstrate a 30–40% response rate and result in approximately 6-month median progression-free...

    Yulei Zhao, Yonina R. Murciano-Goroff, ... Piro Lito in Nature
    Article 10 November 2021
  17. Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3

    T-cell large granular lymphocyte leukemia (T-LGL) is often accompanied by pure red cell aplasia (PRCA). A high depth of next generation sequencing...

    Sooyong Park, Jiwon Yun, ... Hyun Kyung Kim in Scientific Reports
    Article Open access 04 May 2023
  18. A d-2-hydroxyglutarate biosensor based on specific transcriptional regulator DhdR

    d -2-Hydroxyglutarate ( d -2-HG) is a metabolite involved in many physiological metabolic processes. When d -2-HG is aberrantly accumulated due to...

    Dan **ao, Wen Zhang, ... ** Xu in Nature Communications
    Article Open access 07 December 2021
  19. The genomic landscape of cholangiocarcinoma reveals the disruption of post-transcriptional modifiers

    Molecular variation between geographical populations and subtypes indicate potential genomic heterogeneity and novel genomic features within CCA....

    Yaodong Zhang, Zijian Ma, ... **angcheng Li in Nature Communications
    Article Open access 01 June 2022
  20. Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing

    Somatic mutation profiling in gastric cancer (GC) enables main driver mutations to be identified and their clinical and prognostic value to be...

    Marina V. Nemtsova, Alexey I. Kalinkin, ... Vladimir V. Strelnikov in Scientific Reports
    Article Open access 16 January 2020
Did you find what you were looking for? Share feedback.